COVID plasma trial pulled before it even started
NCT ID NCT04411602
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to give blood plasma from recovered COVID-19 patients to people in the ICU with severe COVID-19. The goal was to see if it could help them breathe better and survive. However, the trial was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ascension Macomb-Oakland Hospital, Warren Campus
Warren, Michigan, 48093, United States
-
Ascension Providence Hospital, Novi Campus
Novi, Michigan, 48374, United States
-
Ascension Providence Hospital, Southfield Campus
Southfield, Michigan, 48075, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What happens to the immune system after COVID-19? a major study aims to find out.
- Hidden toll of routine ICU procedure revealed: suctioning may spike pain and stress
- COVID-19's skin secrets: could chilblains hold clues to the virus?
- Scientists create COVID-19 biobank to unlock disease secrets
- What happens to severe COVID-19 survivors after the ICU?
- Experimental cell treatment shows promise for COVID-19 lung failure